Patents Assigned to Verlyx Pharma Inc.
  • Amidine substituted analogues and uses thereof
    Patent number: 11098009
    Abstract: The present application relates to amidine substituted analogues as shown in formula I and uses thereof as an anti-inflammatory agent and/or for the treatment of an immunological disorder or of an inflammatory bowel disease including ulcerative colitis, Crohn's diseases, collagenous colitis and lymphocytic colitis.
    Type: Grant
    Filed: December 21, 2017
    Date of Patent: August 24, 2021
    Assignee: Verlyx Pharma Inc.
    Inventors: François Ravenelle, Michel Therien, Helmi Zaghdane
  • Uses and methods for the treatment of liver diseases or conditions
    Patent number: 9827211
    Abstract: The present application relates methods and uses of oral diamidines or pharmaceutically acceptable salts thereof for the treatment of liver diseases or conditions.
    Type: Grant
    Filed: June 9, 2016
    Date of Patent: November 28, 2017
    Assignee: Verlyx Pharma Inc.
    Inventors: Francois Ravenelle, Pierre Falardeau, Patrick Colin
  • Uses and methods for the treatment of liver diseases or conditions
    Patent number: 9375411
    Abstract: The present application relates methods and uses of oral diamidines or pharmaceutically acceptable salts thereof for the treatment of liver diseases or conditions.
    Type: Grant
    Filed: December 20, 2013
    Date of Patent: June 28, 2016
    Assignee: Verlyx Pharma Inc.
    Inventors: François Ravenelle, Pierre Falardeau, Patrick Colin